Identifying novel PPAR? ligands from cerebellum
Identifying novel PPAR? ligands from cerebellum
批准号:
9281062
负责人:
KALIPADA PAHAN
金额:
$19.38万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2019-06-30
关键词:
Applications GrantsAstrocytesBindingBiological AssayBrainCell DeathCerebellumComputer SimulationCoupledDemyelinating DiseasesEstersExhibitsFatty AcidsFluorescence Resonance Energy TransferFutureGenesHealthLigand Binding DomainLigandsLuciferasesMass Spectrum AnalysisMusMyelinNuclear ExtractNuclear Hormone ReceptorsNuclear TranslocationOligodendrogliaOutcomePPAR-betaPalmitic AcidsPeroxisome Proliferator-Activated ReceptorsPharmaceutical PreparationsPhysiologicalRoleSite-Directed MutagenesisTimeTissuesbasemyelinationnovelremyelination
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Although the classical role of peroxisome proliferator-activated receptor β or δ (PPARβ) is to regulate genes
involved in fatty acid synthesis, PPARβ is highly expressed in the CNS and it participates in many brain
functions including myelination. Being a nuclear hormone receptor, PPARβ needs ligand(s) for its activation
and nuclear translocation. Although there are many synthetic ligands of PPARβ, nothing is known about the
physiological activation of PPARβ by endogenous ligands in the brain. Therefore, we have identified three
possible physiological ligands [1,3-di-tert-butylbenzene (DBB); 2,4-di-tert-butylphenol (DBP); hexadecanoic
acid, methyl ester (HAM)] of PPARβ from nuclear extracts of mouse cerebellum. Here, by using in silico
interaction studies, time-resolved FRET analyses, thermal shift assay, site-directed mutagenesis, and mass
spectrometry, we will characterize whether these physiological molecules are true ligands with PPARβ.
Furthermore, we would like to examine whether these cerebellar ligands exhibit promyelinating effect via
PPARβ. A positive outcome of this grant proposal will highlight the discovery of novel cerebellar ligands of
PPARβ, allowing us to develop cerebellum-based drugs in the future to promote remyelination in
demyelinating disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Remyelination by intranasal TIDM peptide
-
批准号:10582863
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:KALIPADA PAHAN
-
依托单位:
Intranasal TIDM peptide for tauopathy
-
批准号:10274908
-
项目类别:
-
资助金额:$15.7万
-
财政年份:2020
-
负责人:KALIPADA PAHAN
-
依托单位:
Muscle building supplement HMB for remyelination
-
批准号:10442389
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2020
-
负责人:KALIPADA PAHAN
-
依托单位:
Cinnamon and traumatic brain injury
-
批准号:10553165
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:KALIPADA PAHAN
-
依托单位:
Intranasal TIDM peptide for tauopathy
-
批准号:10059127
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2020
-
负责人:KALIPADA PAHAN
-
依托单位:
Muscle building supplement HMB for remyelination
-
批准号:10202489
-
项目类别:
-
资助金额:$71.96万
-
财政年份:2020
-
负责人:KALIPADA PAHAN
-
依托单位:
Cinnamon and traumatic brain injury
-
批准号:9888950
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:KALIPADA PAHAN
-
依托单位:
Muscle building supplement HMB for remyelination
-
批准号:10281373
-
项目类别:
-
资助金额:$6.54万
-
财政年份:2020
-
负责人:KALIPADA PAHAN
-
依托单位:
Muscle building supplement HMB for remyelination
-
批准号:10654820
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2020
-
负责人:KALIPADA PAHAN
-
依托单位:
Cinnamon and traumatic brain injury
-
批准号:10438526
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:KALIPADA PAHAN
-
依托单位:
BLR&D Research Career Scientist Application
-
批准号:10047235
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:KALIPADA PAHAN
-
依托单位:
BLR&D Research Career Scientist Application
-
批准号:10515296
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:KALIPADA PAHAN
-
依托单位:
BLR&D Research Career Scientist Application
-
批准号:10293568
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:KALIPADA PAHAN
-
依托单位:
TLR2-interacting domain of MyD88 peptide for alpha-synucleinopathy
-
批准号:9751988
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2018
-
负责人:KALIPADA PAHAN
-
依托单位:
Identifying novel PPARß ligands from cerebellum
-
批准号:9155665
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2016
-
负责人:KALIPADA PAHAN
-
依托单位:
Characterizing novel hippocampal drugs for Alzheimer's disease
-
批准号:9912071
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2016
-
负责人:KALIPADA PAHAN
-
依托单位:
Characterizing novel hippocampal drugs for Alzheimer's disease
-
批准号:9267405
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2016
-
负责人:KALIPADA PAHAN
-
依托单位:
Characterizing novel hippocampal drugs for Alzheimer's disease
-
批准号:9043549
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2016
-
负责人:KALIPADA PAHAN
-
依托单位:
Characterizing novel hippocampal drugs for Alzheimer's disease
-
批准号:9521184
-
项目类别:
-
资助金额:$15.7万
-
财政年份:2016
-
负责人:KALIPADA PAHAN
-
依托单位:
Cinnamon and its metabolite sodium benzoate in Parkinsonism
-
批准号:10015189
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:KALIPADA PAHAN
-
依托单位:
国内基金
海外基金
Ascl1介导Wnt/beta-catenin通路在TLE海马硬化中反应性Astrocytes异常增生的作用及调控机制
-
批准号:31760279
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2017
-
负责人:丁银秀
-
依托单位: